跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
CANDESARTAN/HCTZ
Authorized
STANDARD
CANDESARTAN/HCTZ
sanis health inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d0cbf1ecd0865bba
Company
sanis health inc
Type
Standard
Approval Details
Approval Id
d0cbf1ecd0865bba
Drug Approval Canada Name
CANDESARTAN/HCTZ
Product Name
CANDESARTAN/HCTZ
Status
Marketed
Status Date
2024-02-21
Original Market Date
2024-02-21
Din
02536064
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
40:28.20
Atc Original
C09DA06 CANDERSARTAN AND DIURETICS
Atc Name
c 09 da 06
Aig Number
0244181002
Company Name
sanis health inc
Company Address
1 Presidents Choice Circle, Brampton, Ontario, Canada, L6Y 5S5
Active Ingredients
CANDESARTAN CILEXETIL
32 MG
HYDROCHLOROTHIAZIDE
12.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d0cbf1ecd0865bba
Type
Standard
Back to Health Canada Approvals
CANDESARTAN/HCTZ - Health Canada Drug Approval Details